T. Rowe Price Associates’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$252K Buy
209,661
+14,193
+7% +$17.1K ﹤0.01% 2605
2025
Q1
$212K Buy
195,468
+14,000
+8% +$15.2K ﹤0.01% 2607
2024
Q4
$318K Buy
181,468
+16,475
+10% +$28.9K ﹤0.01% 2476
2024
Q3
$319K Sell
164,993
-50
-0% -$97 ﹤0.01% 2448
2024
Q2
$293K Buy
165,043
+96,174
+140% +$171K ﹤0.01% 2424
2024
Q1
$187K Buy
68,869
+42,069
+157% +$114K ﹤0.01% 2640
2023
Q4
$60K Sell
26,800
-11,600
-30% -$26K ﹤0.01% 2779
2023
Q3
$112K Hold
38,400
﹤0.01% 2634
2023
Q2
$75K Sell
38,400
-12,300
-24% -$24K ﹤0.01% 2740
2023
Q1
$99K Sell
50,700
-34,200
-40% -$66.8K ﹤0.01% 2689
2022
Q4
$99K Buy
84,900
+23,100
+37% +$26.9K ﹤0.01% 2721
2022
Q3
$68K Buy
61,800
+44,100
+249% +$48.5K ﹤0.01% 2787
2022
Q2
$28K Sell
17,700
-6,961
-28% -$11K ﹤0.01% 2906
2022
Q1
$89K Buy
24,661
+1,900
+8% +$6.86K ﹤0.01% 2859
2021
Q4
$89K Sell
22,761
-28,300
-55% -$111K ﹤0.01% 2885
2021
Q3
$336K Sell
51,061
-7,781
-13% -$51.2K ﹤0.01% 2533
2021
Q2
$362K Buy
58,842
+1,970
+3% +$12.1K ﹤0.01% 2517
2021
Q1
$257K Sell
56,872
-19,845
-26% -$89.7K ﹤0.01% 2608
2020
Q4
$460K Buy
76,717
+43,800
+133% +$263K ﹤0.01% 2273
2020
Q3
$245K Buy
+32,917
New +$245K ﹤0.01% 2361
2017
Q4
Sell
-14,900
Closed -$75K 2575
2017
Q3
$75K Hold
14,900
﹤0.01% 2510
2017
Q2
$60K Hold
14,900
﹤0.01% 2518
2017
Q1
$85K Hold
14,900
﹤0.01% 2506
2016
Q4
$108K Hold
14,900
﹤0.01% 2461
2016
Q3
$119K Sell
14,900
-8,100
-35% -$64.7K ﹤0.01% 2423
2016
Q2
$208K Hold
23,000
﹤0.01% 2310
2016
Q1
$186K Hold
23,000
﹤0.01% 2305
2015
Q4
$249K Buy
+23,000
New +$249K ﹤0.01% 2222